These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3713106)

  • 1. [Acute factitious hyperthyroidism--moderate clinical symptoms in 3 cases under beta-blocker treatment].
    Keck FS; Loos U; Duntas L; Pfeiffer EF
    Klin Wochenschr; 1986 Apr; 64(7):319-26. PubMed ID: 3713106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propranolol and hyperthyroidism: sequential changes in serum iodothyronine (T4, T3, rT3) concentrations during therapy until clinical remission.
    Pinho MO; Medeiros YS; Rosenthal D; Francalanci CC
    Braz J Med Biol Res; 1983 Jul; 16(2):111-7. PubMed ID: 6652288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary report on the use of propranolol in thyrotoxicosis: I. Effect on serum thyroxine, triiodothyronine and reverse triiodothyronine concentrations.
    Tevaarwerk GJ; Malik MH; Boyd D
    Can Med Assoc J; 1978 Aug; 119(4):350-1, 360. PubMed ID: 688126
    [No Abstract]   [Full Text] [Related]  

  • 4. Propranolol, triiodothyronine, reverse triiodothyronine and thyroid disease.
    Feely J; Isles TE; Ratcliffe WA; Crooks J
    Clin Endocrinol (Oxf); 1979 May; 10(5):531-8. PubMed ID: 476982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum T4, T3 and reverse T3 during treatment with propranolol in hyperthyroidism, L-T4 treated myxedema and in normal man.
    Faber J; Friis T; Kirkegaard C; Lumholtz IB; Hansen JM; Siersbaek-Nielsen K; Skovsted L; Theilade P
    Horm Metab Res; 1979 Jan; 11(1):34-6. PubMed ID: 428906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T3-hyperthyroidism caused by enhanced and shifted T4-conversion.
    Loos U; Keck FS; Grau R
    Horm Metab Res Suppl; 1984; 14():85-93. PubMed ID: 6595195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-selective and selective beta-1-adrenoceptor blocking agents in the treatment of hyperthyroidism.
    Nilsson OR; Karlberg BE; Kågedal B; Tegler L; Almqvist S
    Acta Med Scand; 1979; 206(1-2):21-5. PubMed ID: 484256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative influence of propranolol and verapamil on glycemic control and histamine sensitivity associated with L-thyroxine-induced hyperthyroidism - an experimental study.
    Bhatt PA; Makwana D
    Fundam Clin Pharmacol; 2008 Feb; 22(1):53-9. PubMed ID: 18251722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroxine and triiodothyronine levels in hyperthyroid patients during treatment with propranolol.
    Harrower AD; Fyffe JA; Horn DB; Strong JA
    Clin Endocrinol (Oxf); 1977 Jul; 7(1):41-4. PubMed ID: 880733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minor signs and symptoms of toxicity in a young woman in spite of massive thyroxine ingestion.
    Nyström E; Lindstedt G; Lundberg PA
    Acta Med Scand; 1980; 207(1-2):135-6. PubMed ID: 7368967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperthyroxinemia in patients treated with high-dose propranolol.
    Cooper DS; Daniels GH; Ladenson PW; Ridgway EC
    Am J Med; 1982 Dec; 73(6):867-71. PubMed ID: 6816067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of beta-adrenoceptor blocking agents on plasma thyroxine and triiodothyronine.
    Wiersinga WM; Touber JL
    J Clin Endocrinol Metab; 1977 Aug; 45(2):293-8. PubMed ID: 885993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of D- versus L-propranolol in the treatment of hyperthyroidism.
    Eber O; Buchinger W; Lindner W; Lind P; Rath M; Klima G; Langsteger W; Költringer P
    Clin Endocrinol (Oxf); 1990 Mar; 32(3):363-72. PubMed ID: 2344697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of propranolol withdrawal on thyroid hormones in normal and hyperthyroid subjects.
    Ross PJ; Jones MK; John R
    Clin Endocrinol (Oxf); 1980 Jul; 13(1):27-31. PubMed ID: 7438461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propranolol versus carbimazole as the sole treatment for thyrotoxicosis. A consideration of circulating thyroid hormone levels and tissue thyroid function.
    O'Malley BP; Abbott RJ; Barnett DB; Northover BJ; Rosenthal FD
    Clin Endocrinol (Oxf); 1982 Jun; 16(6):545-52. PubMed ID: 7105427
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of neonatal hyperthyroidism due to Graves' disease with sodium ipodate.
    Karpman BA; Rapoport B; Filetti S; Fisher DA
    J Clin Endocrinol Metab; 1987 Jan; 64(1):119-23. PubMed ID: 3782427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of propranolol, atenolol and metoprolol on the serum levels of thyroxin (T4) and triiodothyronine (T3).
    Shikara MM; Maniar R; Steier W; Rao S; Gintautas J
    Proc West Pharmacol Soc; 2003; 46():127. PubMed ID: 14699907
    [No Abstract]   [Full Text] [Related]  

  • 18. Simultaneous measurement of free thyroxine and free 3,5,3'-triiodothyronine in undiluted serum by direct equilibrium dialysis/radioimmunoassay: evidence that free triiodothyronine and free thyroxine are normal in many patients with the low triiodothyronine syndrome.
    Chopra IJ
    Thyroid; 1998 Mar; 8(3):249-57. PubMed ID: 9545112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of circulating thyroxine serum concentration on hepatic thyroxine deiodinating activity in rats.
    Keck FS; Wolf CF; Pfeiffer EF
    Exp Clin Endocrinol; 1990 Dec; 96(3):269-77. PubMed ID: 2083567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of propranolol on thyroid hormones in T3 toxicosis.
    Jones MK; Owens DR; Jones GR; Birtwell J
    Clin Endocrinol (Oxf); 1981 Jun; 14(6):621-3. PubMed ID: 7296908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.